Original Article

Markers of Iron Metabolism and Stroke Risk: Cross-Sectional and Longitudinal Findings from the China Health and Nutrition Survey (CHNS)

Abstract

Background: The association of iron metabolism or status with the stroke risk remains unclear. We aimed to examine the associations between markers of iron metabolism or status and stroke risk using data from the China Health and Nutrition Survey (CHNS).

Methods: Overall, 8589 in the CHNS in 2009, and 7290 participants between 2009 and 2015 were included in the cross-sectional and longitudinal analyses, respectively. Markers included hemoglobin, ferritin (FET), transferrin (TRF), soluble transferrin receptor (sTRF-R), and ratio of sTRF-R/log FET (sTfR-F index). Multivariable logistic regression and Cox proportional hazards models were used to analyze the associations between those markers and risk of stroke. Age, gender, high-sensitivity CRP (hsCRP), body mass index (BMI), current smoking, drinking status, diabetes and hypertension were included as potential confounding factors.

Results: We observed longitudinal associations of hemoglobin (HR: 1.54, 95% CI: 1.15 – 2.06, P = 0.004), and sTfR-F index (HR: 0.68, 95% CI: 0.46 – 0.99, P = 0.044) with stroke risk among the participants whose BMI ≤ 23 kg/m2. In addition, FET levels were significantly associated with stroke risk among female (HR: 1.45, 95% CI: 1.00 – 2.09, P = 0.049) after a median of 6.1 years follow-up. Hemoglobin, FET, TRF, sTRF-R, and sTfR-F index were not associated with the risk of stroke in overall analyses.

Conclusion: FET among female, hemoglobin and sTfR-F index among those BMI ≤ 23 kg/m2 may be contributing factors for stroke.

1. Tuttolomondo A, Di Raimondo D, Pecoraro R, Serio A, D'Aguanno G, Pinto A, Licata G (2010). Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis, 213:311-8.
2. Rajendran SR, Periyasamy S, Manjuladevi MT, George N (2020). Evaluation of Serum Ferritin as a Prognostic Marker in Acute Hemorrhagic Stroke. J Neurosci Rural Pract, 11:72-77.
3. Naess H, Logallo N, Waje-Andreassen U, Thomassen L, Kvistad CE (2019). U-shaped relationship between hemoglobin level and severity of ischemic stroke. Acta Neurol Scand, 140:56-61.
4. Beard JL, Connor JR (2003). Iron status and neural functioning. Annu Rev Nutr, 23:41-58.
5. Rouault TA, Cooperman S (2006). Brain iron metabolism. Semin Pediatr Neurol, 13:142-8.
6. Infusino I, Braga F, Dolci A, Panteghini M (2012). Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. Am J Clin Pathol, 138:642-9.
7. Dimitriou H, Stiakaki E, Markaki EA, Bolonaki I, Giannakopoulou C, Kalmanti M (2000). Soluble transferrin receptor levels and soluble transferrin receptor/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy. Acta Paediatr, 89:1169-73.
8. Benjamin EJ, Blaha MJ, Chiuve SE, et al (2017). Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 135:e146-e603.
9. Zhou M, Wang H, Zeng X, et al (2019). Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 394:1145-1158.
10. Sullivan JL (1981). Iron and the sex difference in heart disease risk. Lancet, 1:1293-4.
11. Egbuche O, Millard HR, Renelus B, et al (2017). Serum Ferritin Levels in Blacks Without Known Cardiovascular Disease (from the Jackson Heart Study). Am J Cardiol, 120:1533-1540.
12. Wei Y, Yang Q, Qin Q, et al (2020). Profiling of the Risk Factors and Designing of a Model to Identify Ischemic Stroke in Patients with Non-Hodgkin Lymphoma: A Multicenter Retrospective Study. Eur Neurol, 83:41-48.
13. Gill D, Monori G, Tzoulaki I, Dehghan A (2018). Iron Status and Risk of Stroke. Stroke, 49:2815-2821.
14. Kim MY, Jee SH, Yun JE, Baek SJ, Lee DC (2013). Hemoglobin concentration and risk of cardiovascular disease in Korean men and women - the Korean heart study. J Korean Med Sci, 28:1316-22.
15. Panwar B, Judd SE, Warnock DG, et al (2016). Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults. Stroke, 47:2017-24.
16. Altamura C, Squitti R, Pasqualetti P, et al (2009). Ceruloplasmin/Transferrin system is related to clinical status in acute stroke. Stroke, 40:1282-8.
17. Knuiman MW, Divitini ML, Olynyk JK, Cullen DJ, Bartholomew HC (2003). Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia. Am J Epidemiol., 158:144-9.
18. Popkin BM, Du S, Zhai F, Zhang B (2010). Cohort Profile: The China Health and Nutrition Survey--monitoring and understanding socio-economic and health change in China, 1989-2011. Int J Epidemiol, 39:1435-40.
19. Yan S, Li J, Li S, Zhang B, Du S, Gordon-Larsen P, Adair L, Popkin B (2012). The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey. Obes Rev, 13:810-21.
20. van der AD, Grobbee DE, Roest M, Marx JJ, Voorbij HA, van der Schouw YT (2005). Serum ferritin is a risk factor for stroke in postmenopausal women. Stroke, 36:1637-41.
21. Harrison PM, Arosio P (1996). The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta, 1275:161-203.
22. Masse PG, Dosy J, Cole DE, Evroski J, Allard J, D'Astous M (2004). Is serum ferritin an additional cardiovascular risk factor for all postmenopausal women? Ann Nutr Metab, 48:381-9.
23. Shin JA, Kim HS, Lee Kang J, Park EM (2020). Estrogen deficiency is associated with brain iron deposition via upregulation of hepcidin expression in aged female mice. Neurobiol Aging, 96:33-42.
24. Kabat GC, Rohan TE (2007). Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control, 18:1047-53.
25. Barazzoni R, Gortan Cappellari G, Ragni M, Nisoli E (2018). Insulin resistance in obesity: an overview of fundamental alterations. Eat Weight Disord, 23:149-157.
26. Aoki I, Taniyama M, Toyama K, Homori M, Ishikawa K (1994). Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin. Stem Cells, 12:329-38.
27. Fernandez-Real JM, McClain D, Manco M (2015). Mechanisms Linking Glucose Homeostasis and Iron Metabolism Toward the Onset and Progression of Type 2 Diabetes. Diabetes Care, 38:2169-76.
28. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS (2002). Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (aric) study. J Am Coll Cardiol, 40:27-33.
29. Goldenstein H, Levy NS, Ward J, Costacou T, Levy AP (2018). Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL. J Diabetes Res, 2018:6125420.
Files
IssueVol 51 No 1 (2022) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v51i1.8302
Keywords
Iron metabolism Ferritin Soluble transferrin receptor Stroke
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Liu D, Zhang Y, Wang C-C, E X-H, Zuo H. Markers of Iron Metabolism and Stroke Risk: Cross-Sectional and Longitudinal Findings from the China Health and Nutrition Survey (CHNS). Iran J Public Health. 2022;51(1):115-123.